# Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST)

> **NCT02203968** · PHASE1,PHASE2 · COMPLETED · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 50 (actual)

## Conditions studied

- Trauma
- Injury
- Bleeding
- Haemorrhage
- Coagulopathy

## Interventions

- **DRUG:** Fibrinogen concentrate
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT02203968
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02203968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02203968, "Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02203968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
